Y-W Cheng

DDX3 loss by p53 inactivation promotes tumor malignancy via the MDM2/Slug/E-cadherin pathway and poor patient outcome in non-small-cell lung cancer

D-W Wu, M-C Lee, Jiaan‐Der Wang et al. · Oncogene · 2013 · 94 citations · Full text

Tumor Biology, Medicine, Pathology +11

c-Myc suppresses microRNA-29b to promote tumor aggressiveness and poor outcomes in non-small cell lung cancer by targeting FHIT

D-W Wu, N-Y Hsu, Y-C Wang et al. · Oncogene · 2014 · 81 citations

Poor Outcomes, Medicine, Immunology +9

The MZF1/c-MYC axis mediates lung adenocarcinoma progression caused by wild-type lkb1 loss

L-H Tsai, J-Y Wu, Y-W Cheng et al. · Oncogene · 2014 · 80 citations

Tumor Biology, Mzf1/c-myc Axis Mediates, Medicine +8

FHIT loss confers cisplatin resistance in lung cancer via the AKT/NF-κB/Slug-mediated PUMA reduction

Dengfeng Wu, M-C Lee, N. Y. Hsu et al. · Oncogene · 2014 · 61 citations · Full text

Oncology, Akt/nf-κb/slug-mediated Puma Reduction, Lung Inflammation +11

Subcellular localization of apurinic endonuclease 1 promotes lung tumor aggressiveness via NF-κB activation

H-H Wu, Y-W Cheng, Jinghua Tsai Chang et al. · Oncogene · 2010 · 47 citations

Cancer Research, Lung Inflammation, Medicine +11